When is dexamethasone indicated for an infant with an upper respiratory infection?

Dexamethasone Indications in Infants with Upper Respiratory Infections

Dexamethasone is NOT routinely indicated for typical viral upper respiratory infections in infants, but has specific indications for croup (laryngotracheobronchitis), bacterial meningitis, and prevention of post-extubation stridor in high-risk mechanically ventilated infants. 1, 2

When Dexamethasone IS Indicated

Croup (Laryngotracheobronchitis)

• Dexamethasone 0.15 mg/kg every 6 hours for 2-4 days is the standard treatment for croup, which presents with barky cough, inspiratory stridor, and hoarseness following an upper respiratory prodrome. 3, 4
• This is the most common indication for dexamethasone in infants with upper respiratory symptoms, as croup affects the upper airways (larynx, trachea, bronchi). 5
• Treatment should be initiated promptly when croup is diagnosed, though timing (immediate vs. delayed by hours) does not significantly affect outcomes. 5

Bacterial Meningitis

• For infants and children ≥6 weeks with suspected or proven bacterial meningitis, dexamethasone 0.15 mg/kg every 6 hours for 2-4 days should be given 10-20 minutes before or concomitant with the first antimicrobial dose. 3
• This indication is critical when bacterial meningitis is in the differential diagnosis of an infant presenting with URI symptoms plus fever, altered mental status, or meningeal signs. 3
• Dexamethasone should NOT be given if antimicrobial therapy has already been initiated, as it is unlikely to improve outcomes in this circumstance. 3

Post-Extubation Prophylaxis (High-Risk Infants Only)

• Dexamethasone reduces the need for reintubation in neonates at high risk for airway edema (those with repeated or prolonged intubations), but should be restricted to this population due to documented side effects including hyperglycemia and glycosuria. 6
• This is relevant for infants with URI who require mechanical ventilation and are being considered for extubation. 6

When Dexamethasone Is NOT Indicated

Typical Viral Upper Respiratory Infections

• The American Academy of Pediatrics recommends against corticosteroids for routine viral URIs, which should be managed with supportive care including adequate hydration, acetaminophen or ibuprofen for fever (in infants >6 months), and gentle nasal suctioning. 1, 2
• Most URIs in infants are viral and self-limited, requiring no pharmacologic intervention beyond symptomatic relief. 2

RSV Bronchiolitis

• Systemic dexamethasone has no proven benefit in RSV bronchiolitis and does not consistently reduce pro-inflammatory cytokines or improve clinical outcomes despite reducing some inflammatory markers like IL-8. 7, 8
• While dexamethasone may lower tracheal IL-8 concentrations in mechanically ventilated children with RSV, this does not translate to clinical benefit in terms of ventilator days or disease severity. 7, 8

Nephrotic Syndrome with URI (Special Population)

• For children with frequently relapsing or steroid-dependent nephrotic syndrome, daily glucocorticoids should NOT be routinely given during URI episodes to reduce relapse risk, based on the 2025 KDIGO guidelines citing the PREDNOS2 study. 3
• The exception is children already on low-dose alternate-day prednisolone with history of repeated infection-associated relapses, where 3 extra doses of low-dose prednisolone (0.5 mg/kg/day) can be considered. 3

Critical Pitfalls to Avoid

• Never prescribe dexamethasone for routine viral URI symptoms without specific indications like croup or bacterial meningitis, as there is no evidence of benefit and potential for harm. 1, 2
• Avoid early postnatal dexamethasone for chronic lung disease prevention in preterm infants, as 4-week regimens are associated with adverse neuromotor outcomes and impaired somatic growth in males at 2-year follow-up. 9
• Do not use dexamethasone after antibiotics have been started for bacterial meningitis, as this negates any potential benefit. 3
• Recognize that stridor following URI suggests croup (warranting dexamethasone), whereas wheezing, tachypnea, and increased work of breathing suggest bronchiolitis (where dexamethasone is not indicated). 1

Red Flags Requiring Urgent Evaluation

• Hypoxemia, severe respiratory distress, apnea, or inability to feed require urgent evaluation or hospitalization regardless of dexamethasone use. 1
• Infants <12 weeks are at higher risk for severe disease and may require closer monitoring even with appropriate dexamethasone therapy when indicated. 1